Using a NanoBRET‐Based Ligand‐Binding Assay at the β2‐Adrenoceptor for Undergraduate Pharmacology Education [PDF]
The teaching of pharmacology includes a fundamental understanding of ligand binding; how it is measured and how it is calculated. We sought to modernize the techniques by which ligand affinity is determined by undergraduate students and introduce them to
Abigail Pearce +10 more
doaj +3 more sources
NanoBRET in C. elegans illuminates functional receptor interactions in real time [PDF]
Background Protein-protein interactions form the basis of every organism and thus, investigating their dynamics, intracellular protein localization, trafficking and interactions of distinct proteins such as receptors and their ligand-binding are of ...
Victoria Elisabeth Groß +4 more
doaj +3 more sources
Visualizing Ligand Binding to a GPCR In Vivo Using NanoBRET [PDF]
Summary: The therapeutic action of a drug depends on its ability to engage with its molecular target in vivo. However, current drug discovery strategies quantify drug levels within organs rather than determining the binding of drugs directly to their ...
Diana C. Alcobia +9 more
doaj +4 more sources
NanoBRET Tracer Development for Class I Bromodomain Target Engagement in Live Cells. [PDF]
ABSTRACT Epigenetic reader proteins, such as bromo-domains, are often associated with diseases such as cancer and inflammation. BET bromodomain inhibitors have been studied extensively; however, non-BET bromodomains are understudied.
Sneddon MS +4 more
europepmc +4 more sources
Multi-Component Mechanism of H2 Relaxin Binding to RXFP1 through NanoBRET Kinetic Analysis [PDF]
Summary: The peptide hormone H2 relaxin has demonstrated promise as a therapeutic, but mimetic development has been hindered by the poorly understood relaxin receptor RXFP1 activation mechanism.
Bradley L. Hoare +8 more
doaj +4 more sources
A Live-Cell NanoBRET Assay to Monitor RNA–Protein Interactions and Their Inhibition by Small Molecules [PDF]
RNA-protein interactions are critical for cellular processes, including translation, pre-mRNA splicing, post-transcriptional modifications, and RNA stability. Their dysregulation is implicated in diseases such as myotonic dystrophy type 1 (DM1) and amyotrophic lateral sclerosis (ALS).
Jingsong Shan +8 more
doaj +4 more sources
Development of a novel NanoBRET high-throughput drug screening assay for human GnRH receptor using sulfo-cyanine 5 fluorophore [PDF]
G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors and targets for over 30% of current clinical drugs, remain crucial for future therapeutic development.
Li Shen +8 more
doaj +2 more sources
Development of a Lysine-Reactive Targeted Covalent Inhibitor for the P300/CBP-Associated Factor Bromodomain Through Structure-Based Design. [PDF]
We developed a targeted covalent inhibitor for the p300/CBP‐associated factor (PCAF) bromodomain. Our lead molecule, 10, labeled a unique lysine residue in the PCAF bromodomain, demonstrated potent inhibition in biophysical/biochemical assays, and engaged the PCAF bromodomain in cells.
Ede RR +9 more
europepmc +2 more sources
NanoBRET-based detection of ligand-receptor interactions at the neuropeptide FF receptor 1. [PDF]
Characterization of ligand binding at the neuropeptide FF receptor 1 (NPFFR1) through a nanoBRET-based assay.
Lentschat H, Beck-Sickinger AG.
europepmc +2 more sources
Proximity labeling reveals non-catalytic interactions between DPP9 and ubiquitin signaling complexes [PDF]
Dipeptidyl peptidase 9 (DPP9) is an amino-peptidase with roles in immunity, DNA-repair, cell signaling, memory and neonatal survival; its dysregulation is linked to cancer and immune-related disorders.
Valentina Elena Wirtgen +10 more
doaj +2 more sources

